https://www.pharmaceutical-technolo...gic-encephalomyelitis-likelihood-of-approval/ Data Insights December 31, 2024 Norketotifen by Emergo Therapeutics for Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): Likelihood of Approval Brought to you by Emergo Therapeutics Norketotifen Norketotifen is under clinical development by Emergo Therapeutics and currently in Phase I for Chronic Fatigue Syndrome (Myalgic Encephalomyelitis). According to GlobalData, Phase I drugs for Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) does not have sufficient historical data to build an indication benchmark PTSR for Phase I. GlobalData uses proprietary data and analytics to create drugs-specific PTSR and LoA in the Norketotifen LoA Report. Buy the report here. GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Norketotifen overview Norketotifen is under development for the treatment of flu and flu-like viral infections ,allergic rhinitis, unspecified influenza virus Infections and influenza like illness, chronic fatigue syndrome (myalgic encephalomyelitis) and coronavirus disease 2019 (COVID-19). The drug candidate is administered as oral capsule. It is the metabolite or byproduct of ketotifen. It acts by targeting histamine H1 receptors. Emergo Therapeutics overview Emergo Therapeutics is developing immunomodulator to treat coronavirus disease. The company is headquartered in Durham, North Carolina, the US. For a complete picture of Norketotifen’s drug-specific PTSR and LoA scores, buy the report here.
So you could just give people ketotifen and, erm, let them metabolise it themselves? Actually, that's a ridiculous suggestion. The patent will have expired.
To be fair I think I’ve read on social media if quite a few people who’ve been describe ketotifen or other things for eg mCAS and it hasn’t agreed with them if they can’t tolerate it I’ve no idea whether it being in this gif makes it worse or better regarding this of course
